These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23060485)

  • 1. Exposure of family members to antineoplastic drugs via excreta of treated cancer patients.
    Yuki M; Sekine S; Takase K; Ishida T; Sessink PJ
    J Oncol Pharm Pract; 2013 Sep; 19(3):208-17. PubMed ID: 23060485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antineoplastic drug residues inside homes of chemotherapy patients.
    Böhlandt A; Sverdel Y; Schierl R
    Int J Hyg Environ Health; 2017 Jun; 220(4):757-765. PubMed ID: 28372941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of a closed system device to reduce occupational contamination and exposure to antineoplastic drugs in the hospital work environment.
    Yoshida J; Tei G; Mochizuki C; Masu Y; Koda S; Kumagai S
    Ann Occup Hyg; 2009 Mar; 53(2):153-60. PubMed ID: 19261696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary Exposure of Family Members to Cyclophosphamide After Chemotherapy of Outpatients With Cancer: A Pilot Study.
    Yuki M; Ishida T; Sekine S
    Oncol Nurs Forum; 2015 Nov; 42(6):665-71. PubMed ID: 26488834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a closed system drug-transfer device eliminates surface contamination with antineoplastic agents.
    Clark BA; Sessink PJ
    J Oncol Pharm Pract; 2013 Jun; 19(2):99-104. PubMed ID: 23292973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antineoplastic drug contamination in the urine of Canadian healthcare workers.
    Hon CY; Teschke K; Shen H; Demers PA; Venners S
    Int Arch Occup Environ Health; 2015 Oct; 88(7):933-41. PubMed ID: 25626912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological monitoring of occupational exposure to antineoplastic drugs in hospital settings.
    Sabatini L; Barbieri A; Lodi V; Violante FS
    Med Lav; 2012; 103(5):394-401. PubMed ID: 23077799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Occupational exposures among nurses caring for chemotherapy patients -Quantitative analysis of cyclophosphamide and α-fluoro-β-alanine in urine].
    Sasaki M; Ishii N; Kikuchi Y; Kudoh Y; Sugiyama R; Hasebe M
    Sangyo Eiseigaku Zasshi; 2016 Oct; 58(5):164-172. PubMed ID: 27488511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological monitoring of occupational exposure to 5-fluorouracil: urinary α-fluoro-β-alanine assay by high performance liquid chromatography tandem mass spectrometry in health care personnel.
    Ndaw S; Denis F; Marsan P; d'Almeida A; Robert A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(27):2630-4. PubMed ID: 20207593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineoplastic drug contamination on the hands of employees working throughout the hospital medication system.
    Hon CY; Teschke K; Demers PA; Venners S
    Ann Occup Hyg; 2014 Jul; 58(6):761-70. PubMed ID: 24644303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary elimination of cyclophosphamide alkylating metabolites and free thiols following two administration schedules of high-dose cyclophosphamide and mesna.
    Fleming RA; Cruz JM; Webb CD; Kucera GL; Perry JJ; Hurd DD
    Bone Marrow Transplant; 1996 Apr; 17(4):497-501. PubMed ID: 8722345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occupational exposure to antineoplastic agents at several departments in a hospital. Environmental contamination and excretion of cyclophosphamide and ifosfamide in urine of exposed workers.
    Sessink PJ; Boer KA; Scheefhals AP; Anzion RB; Bos RP
    Int Arch Occup Environ Health; 1992; 64(2):105-12. PubMed ID: 1399019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hygienic guidance values for wipe sampling of antineoplastic drugs in Swedish hospitals.
    Hedmer M; Wohlfart G
    J Environ Monit; 2012 Jul; 14(7):1968-75. PubMed ID: 22692549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of healthcare workers' exposure to cyclophosphamide, ifosfamide, methotrexate, and 5-fluorouracil by 24-h urine assay: A descriptive pilot study.
    Palamini M; Dufour A; Therrien R; Delisle JF; Mercier G; Gagné S; Caron N; Bussières JF
    J Oncol Pharm Pract; 2020 Dec; 26(8):1864-1870. PubMed ID: 32138611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between occupational exposure and control measures for antineoplastic drugs in a pharmacy of a hospital.
    Yoshida J; Koda S; Nishida S; Nakano H; Tei G; Kumagai S
    Ann Occup Hyg; 2013 Mar; 57(2):251-60. PubMed ID: 23002276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of methods for environmental monitoring of cyclophosphamide in workplaces.
    Hedmer M; Jönsson BA; Nygren O
    J Environ Monit; 2004 Dec; 6(12):979-84. PubMed ID: 15568047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nurses' internal contamination by antineoplastic drugs in hospital centers: a cross-sectional descriptive study.
    Villa A; Molimard M; Sakr D; Lassalle R; Bignon E; Martinez B; Rouyer M; Mathoulin-Pelissier S; Baldi I; Verdun-Esquer C; Canal-Raffin M
    Int Arch Occup Environ Health; 2021 Nov; 94(8):1839-1850. PubMed ID: 34021808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the efficacy of additional measures introduced for the protection of healthcare personnel handling antineoplastic drugs.
    Odraska P; Dolezalova L; Kuta J; Oravec M; Piler P; Blaha L
    Ann Occup Hyg; 2013 Mar; 57(2):240-50. PubMed ID: 22926784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assay of urinary alpha-fluoro-beta-alanine by gas chromatography-mass spectrometry for the biological monitoring of occupational exposure to 5-fluorouracil in oncology nurses and pharmacy technicians.
    Rubino FM; Verduci C; Buratti M; Fustinoni S; Campo L; Omodeo-Salè E; Giglio M; Iavicoli S; Brambilla G; Colombi A
    Biomed Chromatogr; 2006 Mar; 20(3):257-66. PubMed ID: 16167301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of cyclophosphamide in the urine of antineoplastic drugs handlers].
    Favier B; Gilles L; Desage M; Latour JF
    Bull Cancer; 2003 Oct; 90(10):905-9. PubMed ID: 14706919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.